Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: A case report

dc.contributor.author	Christodoulou C
dc.contributor.author	Papadopoulou A
dc.contributor.author	Rizos E
dc.contributor.author	Tournikioti K
dc.contributor.author	Gonda Xénia
dc.contributor.author	Douzenis A
dc.contributor.author	Lykouras L
dc.date.accessioned	2014-12-12T08:25:36Z
dc.date.available	2014-12-12T08:25:36Z
dc.date.issued	2010
dc.identifier	76749091920
dc.identifier.citation	pagination=5; journalVolume=9; journalTitle=ANNALS OF GENERAL PSYCHIATRY;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/763
dc.identifier.uri	doi:10.1186/1744-859X-9-5
dc.description.abstract	Background: We present the case of a 52-year-old woman with depression who developed extrapyramidal symptoms (mainly parkinsonism) and suicidal ideation while on fluoxetine.Methods: The patient underwent neurological and neuroimaging examination.Results: The patient's neurological and neuroimaging examinations were normal and there was no other cause of extrapyramidal symptoms. The patient showed remission of the aforementioned symptomatology when fluoxetine was discontinued.Conclusions: This case shows that fluoxetine can be associated with extrapyramidal symptoms, and this may have an aggravating affect on clinical depression progress and the emergence of suicidal ideation. © 2010 Christodoulou et al; licensee BioMed Central Ltd.
dc.relation.ispartof	urn:issn:1744-859X
dc.title	Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: A case report
dc.type	Journal Article
dc.date.updated	2014-12-11T13:48:08Z
dc.language.rfc3066	en
dc.identifier.mtmt	1801040
dc.identifier.wos	000208606200005
dc.identifier.pubmed	20148108
dc.contributor.department	SE/ÁOK/K/Kútvölgyi Klinikai Tömb egyéb osztályok
dc.contributor.institution	Semmelweis Egyetem